Hikma Pharmaceuticals PLC (LON: HIK)

Hikma Pharmaceuticals Revenue

In the year 2023, Hikma Pharmaceuticals had annual revenue of $2.88B USD with 14.22% growth. Revenue in the quarter ending December 31, 2023 was $1.45B USD with 8.30% year-over-year growth.

• Revenue: $2.88B
• Revenue Growth: +12.61%
• P/S Ratio: 1.81
• Revenue / Employee: $315,934
• Employees: 9,100
• Market Cap: 4.09B GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	2.88B	358.00M	14.22%
Dec 31, 2022	2.52B	-36.00M	-1.41%
Dec 31, 2021	2.55B	212.00M	9.06%
Dec 31, 2020	2.34B	134.00M	6.07%
Dec 31, 2019	2.21B	137.00M	6.62%
Dec 31, 2018	2.07B	134.00M	6.92%
Dec 31, 2017	1.94B	-14.00M	-0.72%
Dec 31, 2016	1.95B	510.00M	35.42%
Dec 31, 2015	1.44B	-49.00M	-3.29%
Dec 31, 2014	1.49B	124.00M	9.08%
Dec 31, 2013	1.37B	256.28M	23.11%
Dec 31, 2012	1.11B	190.70M	20.77%
Dec 31, 2011	918.03M	187.09M	25.60%
Dec 31, 2010	730.94M	94.05M	14.77%
Dec 31, 2009	636.88M	56.23M	9.68%
Dec 31, 2008	580.66M	131.86M	29.38%
Dec 31, 2007	448.80M	131.77M	41.57%
Dec 31, 2006	317.02M	54.81M	20.90%
Dec 31, 2005	262.22M	49.84M	23.47%
Dec 31, 2004	212.38M	107.23M	101.98%
Dec 31, 2003	105.15M	19.65M	22.98%
Dec 31, 2002	85.50M	-	-